Global Therapies and Diagnostics for Cervical Cancer Market
As the global economy mends, the 2021 growth of Therapies and Diagnostics for Cervical Cancer wil ... Read More
As the global economy mends, the 2021 growth of Metagenomics Sequencing will have significant change from previous year. According to our (LP Information) latest study, the global Metagenomics Sequencing market size is USD million in 2022 from USD 812.3 million in 2021, with a change of % between 2021 and 2022. The global Metagenomics Sequencing market size will reach USD 1583 million in 2028, growing at a CAGR of 10.0% over the analysis period.
The United States Metagenomics Sequencing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metagenomics Sequencing market, reaching US$ million by the year 2028. As for the Europe Metagenomics Sequencing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metagenomics Sequencing players cover Agilent Technologies, Enterome SA, F. Hoffmann, and Illumina, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metagenomics Sequencing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Instrument and Software
Consumables
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Infectious Disease Diagnosis
Environmental Remediation
Gut Microbe Characterization
Biotechnology
Biofuel
Agriculture
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Agilent Technologies
Enterome SA
F. Hoffmann
Illumina
Oxford Nanopore Technologies
Pacific Biosciences of California
PerkinElmer
Qiagen
Swift Biosciences
Thermo Fisher Scientific
As the global economy mends, the 2021 growth of Therapies and Diagnostics for Cervical Cancer wil ... Read More
As the global economy mends, the 2021 growth of Sleep Apnea Diagnostics and Therapeutics will hav ... Read More
As the global economy mends, the 2021 growth of Smart Pills Technology will have significant chan ... Read More
As the global economy mends, the 2021 growth of Kidney & Renal Cancer Drugs will have significant ... Read More